The alteration of Fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillance in vivo?

Hepatology

Volumn 30, Issue 2, 1999, Pages 413-421

  Nagao, Mitsuo ^a   Nakajima, Yoshiyuki ^a   Hisanaga, Michiyoshi ^a   Kayagaki, Nobuhiko ^b   Kanehiro, Hiromichi ^a   Aomatsu, Yukio ^a   Saiho, Ko ^a   Yagita, Hideo ^b   Yamada, Takatsugu ^a   Okumura, Ko ^b   Nakano, Hiroshige ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEPATOMA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032783244     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300237     Document Type: Article

References (13)

1. Nagata S, Golstein, P. The Fas death factor. Science 1995;267:1449-1456.
2. Krammer PH, Behrmann I, Daniel P, Dhein D, Dehatin K-M. Regulation of apoptosis in the immune system. Curr Opin Immunol 1994;6:279-289.
3. Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathway. Nature 1994;370:650-652.
4. Kagi D, Vignaux F, Ledermann B, Būrki K, Depraetere V, Nagata S, Hengartner H, et al. Fas and perforin pathways as major mechanisms of T-cell mediated cytotoxicity. Science 1994;265:528-530.
5. +independent T cell-mediated cytotoxicity. J Exp Med 1993;177:195-200.
6. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, et al. Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity. Proc Natl Acad Sci U S A 1994;91:4930-4934.
7. + cytotoxic T cells. Proc Natl Acad Sci U S A 1994;91:4185-4189.
8. + T-cell mediated cytotoxicity. Immunology 1994;152:1127-1133.
9. Dhein J, Walczak H, Bāumler C, Debatin K-M, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-441.
10. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-444.
11. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-448.
12. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995;181:71-77.
13. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989:169:1747-1756.